Jonathan Cullis

Fludarabine, cytarabine, G‐CSF and idarubicin (FLAG‐IDA) for the treatment of poor‐risk myelodysplastic syndromes and acute myeloid leukaemia

Jane E. Parker, Antonio Pagliuca, Aleksandar Mijović et al. · British Journal of Haematology · 1997 · 164 citations

Medicine, Hematology, Pharmacotherapy +17

A novel 33‐Gene targeted resequencing panel provides accurate, clinical‐grade diagnosis and improves patient management for rare inherited anaemias

Noémi Roy, Edward A. Wilson, Shirley Henderson et al. · British Journal of Haematology · 2016 · 90 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Clonal diversity in the myeloproliferative neoplasms: independent origins of genetically distinct clones

Philip Beer, Amy V. Jones, Anthony J. Bench et al. · British Journal of Haematology · 2009 · 86 citations · Full text

Medicine, Genetics, Hematology +17

Interpreting raised serum ferritin levels

Marianna Koperdanova, Jonathan Cullis · BMJ · 2015 · 85 citations

Medicine, Hematology, Iron Metabolism Disorders +16

Post‐Transfusion Hyperhaemolysis in a Patient with Sickle Cell Disease: Use of Steroids and Intravenous Immunoglobulin to Prevent Further Red Cell Destruction

Jonathan Cullis, Nay Win, John M. Dudley et al. · Vox Sanguinis · 1995 · 80 citations

Medicine, Hematology, Hematopathology +16